WSJ Investigation Series Led to Elizabeth Holmes' Downfall at Theranos
A series of Wall Street Journal investigative articles examined blood-testing company Theranos and its founder Elizabeth Holmes, raising questions about the company's technology and practices. The reporting is credited with setting in motion the events that led to Holmes' eventual downfall.
GoKawiil's interpretation of the reporting above, not reported fact.
The case illustrates how investigative journalism can expose discrepancies between a startup's public claims and its actual technology, particularly in health-related fields where inaccurate testing could endanger patients. It also underscores the role of a free press in holding well-funded, high-profile founders accountable even amid strong public and investor enthusiasm.
- WSJ investigative reporting scrutinized Theranos' blood-testing claims and practices.
- The coverage is linked to the broader unraveling of Elizabeth Holmes' company and reputation.
- The case highlights journalism's role in uncovering corporate misrepresentation in health technology.
Bad Blood by John Carreyrou — This is the definitive account of the Theranos scandal, written by the Wall Street Journal reporter who broke the story. It dives deep into how Elizabeth Holmes built and sustained the fraud, offering far more detail than any single article could provide.
See Bad Blood by John Carreyrou on Amazon → Affiliate link — we may earn a commission on purchases, at no extra cost to you. Product picked by AI based on this article; it is not a tested recommendation.Source: wsj.com, 2026-10-22
Published there as: “The Wall Street Journal Investigation That Exposed Elizabeth Holmes”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.